Can exercise together ease the burden of brain tumors?
NCT ID NCT07278440
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot trial tests whether a supervised, group exercise program called Exercise Together is safe and feasible for people with primary brain tumors and their caregivers. The program uses resistance training to strengthen muscles used in daily activities and is designed to foster teamwork. Researchers will enroll 36 patient-caregiver pairs to see if they can stick with the program and if it improves their mental and physical health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Resistance training (Exercise Together program)
What this could lead to
If it works, this could point toward a safe, effective way to improve daily functioning and reduce distress for brain tumor patients and their caregivers.
What could go wrong
This is a very small pilot study (36 people) testing feasibility first, not effectiveness. It may not show clear benefits or be too demanding for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BRAIN NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact